A

Adaptive Biotechnologies Corp
D

ADPT

6.32000
USD
-0.09
(-1.40%)
مفتوح الان
حجم التداول
13,497
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
932,702,352
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ILMN
    ILMN
    -2.040
    (-1.50%)
    133.890 USD
    M
    MTD
    -8.41
    (-0.68%)
    1,224.00 USD
    M
    MYGN
    0.120
    (0.90%)
    13.480 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    O
    OPK
    -0.02500
    (-1.62%)
    1.51500 USD
    P
    PKI
    1.920
    (1.57%)
    124.190 USD
    P
    PODD
    -6.11
    (-2.29%)
    260.30 USD
    TMO
    TMO
    -2.14
    (-0.41%)
    521.39 USD
    T
    TNDM
    -0.100
    (-0.28%)
    35.800 USD
    V
    VEEV
    -1.600
    (-0.71%)
    222.570 USD
    المزيد
الأخبار
المقالات

العنوان: Adaptive Biotechnologies Corp

القطاع: Healthcare
الصناعة: Biotechnology
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).